Lu Li
Stock Analyst at UBS
(1.43)
# 3,565
Out of 5,156 analysts
15
Total ratings
66.67%
Success rate
-2.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Maintains: Neutral | $8 → $6 | $4.81 | +24.74% | 5 | Feb 24, 2026 | |
| QDEL QuidelOrtho | Maintains: Neutral | $31 → $35 | $19.86 | +76.23% | 4 | Jan 21, 2026 | |
| VCYT Veracyte | Maintains: Buy | $42 → $48 | $33.37 | +43.84% | 5 | Nov 5, 2025 | |
| FLGT Fulgent Genetics | Upgrades: Buy | $20 → $30 | $14.88 | +101.61% | 1 | Aug 5, 2025 |
Myriad Genetics
Feb 24, 2026
Maintains: Neutral
Price Target: $8 → $6
Current: $4.81
Upside: +24.74%
QuidelOrtho
Jan 21, 2026
Maintains: Neutral
Price Target: $31 → $35
Current: $19.86
Upside: +76.23%
Veracyte
Nov 5, 2025
Maintains: Buy
Price Target: $42 → $48
Current: $33.37
Upside: +43.84%
Fulgent Genetics
Aug 5, 2025
Upgrades: Buy
Price Target: $20 → $30
Current: $14.88
Upside: +101.61%